APCC combines the most advanced multi-modal treatment protocols to battle and conquer cancer. We bring to the table the the most cutting-edge advancements in the areas of surgical, medical and radiation oncology. Other than introducing game-changing equipment like Radixact Tomotherapy and Proton Beam Therapy, our focus at APCC is to raise the benchmark across all the touch-points in the entire cancer care spectrum. From screening, to nursing to treatment and rehabilitation our experts at APCC are pushing the envelope in terms of clinical excellence and outcomes in oncology.


Medical Oncology is the use of powerful therapeutics to launch a sustained attack on cancer cells. There has been tremendous strides in this crucial field – Medical Oncology moved beyond conventional chemotherapy and now straddles new and revolutionary facets like personalized systemic treatments, targeted therapy, hormonal therapy and immunotherapy. APCC’s multi-disciplinary approach leverages great expertise and skill in Medical Oncology to augment our radiation and surgical treatment to provide patients with a comprehensive and 360-degree treatment blueprint.

At APCC, the protocols are tailor-made to the patient’s specific type of cancer. Our specialists use state-of-the-art genetic sequencing to identify key genetic mutations in a patient’s tumour; these individual variations in genes allow doctors to administer very focussed tumour categories and prescribe treatments to address the cancers’ individual makeup. 

Our Medical Oncology offering includes :

Personalised Therapy

At APCC we operate on the cutting edge of chemotherapy. A battery of advanced tests and profiling indicates the optimal drug for the treatment of each specific case; this kind of treatment is more focused and personalised and is more valuable in combating cancer and helping the patient to conquer it more effectively and efficiently.

Targeted therapy

At APCC we use the precision medicine approach to deliver personalized and targeted cancer treatment. We use therapeutics to target specific genes or proteins that make up cancer cells and launch an all-out attack on them to arrest the growth and spread of the cancer cells.

Our approach is to identify potential targets by comparing the amounts of individual proteins in cancer cells and in normal cells. Proteins that are present in cancer cells but not normal cells or that are more abundant in cancer cells would be potential targets, especially if they are known to be involved in cell growth or survival

Hormone therapy

Hormone therapy fights cancer by changing the amount of hormones in the body to treat certain forms of cancer that rely on these chemicals to grow and spread. We use drugs to prevent hormones from making cancer cells grow and divide.


Immunotherapy leverages the patient’s immune system to form an effective arsenal against cancer. The immune system is our first line of defence against cancer; immune cells patrol the body and vigilantly look out for cells that are not normal, such as bacteria, viruses and cancer cells, and try to destroy them. We activate immune cells to fight against cancer cells in any of the following ways:

Molecular Profiling

Molecular profiling is a great catalyst to improve efficacy of systemic therapies. Our expert pathologists and molecular biologists analyse the cancer tissue sample collected during biopsy or from the patient's blood sample and perform rigorous molecular biology testing on them. These tests predict the patient’s chance of responding to cancer drugs when administered for treatment. This forms the basis for bespoke treatment plans for individual cases of cancer.

Genetic Profiling

In Genetic profiling, the gene mutation of the cancerous cells is checked to predict whether the patient can respond to a particular drug or not.